Cytek Biosciences Inc. (CTKB) said that its Chief Operating Officer, Chris Williams, will resign his position effective September 27, 2024, to accept a chief executive officer position at another company. Cytek said it has chosen not to replace the Chief Operating Officer position, opting instead to restructure the organization to create a flatter, more efficient management structure.The company noted that Williams will remain with the company until September 27, 2024, to ensure a smooth transition and assist with the restructuring process.

Cytek Biosciences Inc.（CTKB）表示，其首席运营官克里斯·威廉姆斯（ChrisWilliams）将于2024年9月27日辞职，接受另一家公司的首席执行官职位。Cytek表示，它选择不取代首席运营官的职位，而是选择重组公司，以创建一个更扁平、更高效的管理结构。该公司指出，威廉姆斯将留在公司直到2024年9月27日，以确保平稳过渡并协助重组过程。

For comments and feedback contact: editorial@rttnews.comBusiness News.

如需评论和反馈，请联系：editorial@rttnews.comBusiness新闻。

Biotech Stocks Facing FDA Decision In August 2024

2024年8月美国食品和药物管理局（FDA）决定生物技术股

Biotech Stocks Facing FDA Decision In June 2024

2024年6月美国食品和药物管理局（FDA）决定生物技术股

Biotech Stocks Facing FDA Decision In April 2024